You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancer

  • Technology appraisal guidance
  • Reference number: TA411
  • Published:  28 September 2016
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Final appraisal determination
  2. Draft guidance
  3. Notes
  4. Draft scope documents
  5. Invitation to participate

History

Documents created during the development process.

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 321 KB)

    Published:
    12 August 2016
  • Committee papers (PDF 286 KB)

    Published:
    12 August 2016
  • Committee papers Slides (PDF 81 KB)

    Published:
    12 August 2016

Draft guidance

  • Appraisal consultation document (PDF 328 KB)

    Published:
    26 May 2016
  • Committee papers (PDF 12.23 MB)

    Published:
    26 May 2016

Notes

  • Note

Draft scope documents

  • Draft scope (pre-referral) (PDF 186 KB)

    Published:
    26 November 2015
  • Provisional matrix (pre-referral) (PDF 177 KB)

    Published:
    26 November 2015

Invitation to participate

  • Final scope (PDF 165 KB)

    Published:
    18 November 2015
  • Final matrix (PDF 175 KB)

    Published:
    18 November 2015
  • Draft scope and provisional matrix comments table (post-referral) (PDF 201 KB)

    Published:
    18 November 2015
  • Equality impact assessment (Scoping) (PDF 64 KB)

    Published:
    18 November 2015
Back to top